MedTrace Logo

Elobixibat for Chronic Constipation Without Defecation Desire

NCT05165199 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-03-23

No results posted yet for this study

Summary

Patients of chronic constipation without defecation desire will be orally administered elobixibat 10 mg once daily before meals for 4 weeks. The primary endpoint of the pre/post comparative study will be the percentage of improvement in bowel movements from Week 2 of the observation period at Week 4 of the treatment period.

Conditions

  • Chronic Constipation

Interventions

DRUG

Elobixibat 10mg

Patients of chronic constipation with loss of defecation desire are administered Elobixibat 10mg for 4 weeks

Sponsors & Collaborators

  • Yokohama City University

    lead OTHER

Principal Investigators

  • Takaomi Kessoku, M.D., PhD. · Yokohama City University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2022-09-30
Completion
2023-03-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05165199 on ClinicalTrials.gov